Spring 2024 Management B8516 section 001

Lab-to-Market: Accelerating Biomedical I

Lab-to-Market

Call Number 18478
Day & Time
Location
T 4:10pm-7:25pm
620 Kravis Hall
Points 3
Grading Mode Standard
Approvals Required None
Instructors Megan Heenan
Dennis Purcell
Type LECTURE
Method of Instruction In-Person
Course Description Lab-to-Market: Accelerating Biomedical Innovation is a 3-credit, semester-long course offered in partnership with the School of Engineering (SEAS), Columbia Business School (CBS) and Columbia's Life Science Accelerators (Biomedical Engineering Technology Accelerator (BiomedX), Therapeutics Accelerator (TRx), Accelerating Cancer Therapeutics (ACT). Students collaborate with experienced technical teams from the Accelerators to create aspects of a commercialization plan for real world, cutting-edge medical technologies currently under development. Students work closely with their interdisciplinary team to identify the clinical need, stakeholder requirements, and business case in order to de-risk the technology, increase commercial potential, and package the idea for follow-on investment. In the second half of the course, students will also gain exposure to life sciences entrepreneurship and investing with complementary case studies of real life science innovation to commercialization provided by entrepreneurial leaders in biotech and medtech.
Web Site Vergil
Department MANAGEMENT
Enrollment 25 students (30 max) as of 9:06PM Friday, December 6, 2024
Subject Management
Number B8516
Section 001
Division School of Business
Open To Business, Journalism
Section key 20241MGMT8516B001